Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Spaccarotella E, Pellegrino E, Ferracin M, Ferreri C, Cuccuru G, Liu C, et al. STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma. Haematologica. 2014;99(1):116-24.

Magro CM, Hagen JW, Crowson AN, Liu YC, Mihm M, Drucker NM, et al. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides. J Dermatol. 2014;41(7):609-17.

Kamal L, Salvatore S, Hartono C, Perlman A. Concomitance of IgA nephropathy and diabetic nephropathy in a kidney allograft: case report and review of the literature. Transplant Proc. 2014;46(7):2396-9.

Hartono C, Chung M, Kuo SF, Seshan SV, Muthukumar T. Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy. J Nephrol. 2014;27(1):103-6.

Samad A, Conway AB, Attam R, Jessurun J, Pambuccian SE. Cytologic features of pancreatic adenocarcinoma with "vacuolated cell pattern." report of a case diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol. 2014;42(4):302-7.

VandenBussche CJ, Wakely PE, Siddiqui MT, Maleki Z, Ali SZ. Cytopathologic characteristics of epithelioid vascular malignancies. Acta Cytol. 2014;58(4):356-66.

Rohan TE, Xue X, Lin H-, D'Alfonso TM, Ginter PS, Oktay MH, et al. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. J Natl Cancer Inst. 2014;106(8).

Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13(23):3670-84.

Hu Z, Chen K, Xia Z, Chavez M, Pal S, Seol J-, et al. Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging. Genes Dev. 2014;28(4):396-408.

Kong F, Zhang J, Li Y, Hao X, Ren X, Li H, et al. Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases. Oncogene. 2014;33(8):986-95.